Consider alternatives if: Cost is your primary concern and you want flat-rate pricing that does not increase with dose escalation
These should resolve in 35 days of use
The American Diabetes Association recommends reassessing glycemic control within 3 months of any significant medication change
Important protocol deviations were reported for 62 of all randomised participants (15.0%), with two-thirds ( n =41) due to restricted medication use
Potential contributors may include baseline reward sensitivity, emotional eating tendency, metabolic status, diabetes status, medication adherence, gastrointestinal tolerability, prior dietary patterns, and broader psychological context, but these variables have not yet been systematically integrated